BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31357959)

  • 1. Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.
    Dapper H; Schiller K; Münch S; Peeken JC; Borm K; Weber W; Combs SE
    BMC Cancer; 2019 Jul; 19(1):742. PubMed ID: 31357959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes.
    Frennered A; Scherman J; Buchwald P; Johnsson A; Sartor H; Zackrisson S; Trägårdh E; Nilsson MP
    BMC Cancer; 2021 Apr; 21(1):447. PubMed ID: 33888074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation.
    Garda AE; Navin PJ; Merrell KW; Martenson JA; Neben Wittich MA; Haddock MG; Sio TT; Rule WG; Ashman JB; Sheedy SP; Hallemeier CL
    Radiother Oncol; 2020 Aug; 149():128-133. PubMed ID: 32417349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.
    Ng M; Leong T; Chander S; Chu J; Kneebone A; Carroll S; Wiltshire K; Ngan S; Kachnic L
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1455-62. PubMed ID: 22401917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Castellano I; Cassoni P; Ricardi U; Munoz F; Racca P; Contu V; Beltramo G; Morino M; Mussa A
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):73-8. PubMed ID: 19632066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients.
    Borm KJ; Voppichler J; Düsberg M; Oechsner M; Vag T; Weber W; Combs SE; Duma MN
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):574-582. PubMed ID: 30118822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy.
    Schiller K; Stöhrer L; Düsberg M; Borm K; Devecka M; Vogel MME; Tauber R; Heck MM; Rauscher I; Eiber M; Gschwend JE; Duma MN; Combs SE
    Eur Urol Oncol; 2021 Feb; 4(1):73-83. PubMed ID: 32451312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of positron emission tomography-computed tomography in the management of anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of organs at risk using different contouring guidelines for definition of the clinical target volume in anal cancer.
    Dapper H; Oechsner M; Münch S; Diehl C; Peeken JC; Borm K; Combs SE
    Strahlenther Onkol; 2020 Apr; 196(4):368-375. PubMed ID: 32016496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.
    Myerson RJ; Garofalo MC; El Naqa I; Abrams RA; Apte A; Bosch WR; Das P; Gunderson LL; Hong TS; Kim JJ; Willett CG; Kachnic LA
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):824-30. PubMed ID: 19117696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
    Keenan LG; Rock K; Azmi A; Salib O; Gillham C; McArdle O
    Radiother Oncol; 2018 Jun; 127(3):417-422. PubMed ID: 29523410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients.
    Slim N; Passoni P; Incerti E; Tummineri R; Gumina C; Cattaneo GM; De Nardi P; Canevari C; Fiorino C; Ronzoni M; Tamburini AM; Burgio V; Gianolli L; Di Muzio N
    Sci Rep; 2020 Sep; 10(1):14613. PubMed ID: 32884036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of
    Schiller K; Devecka M; Maurer T; Eiber M; Gschwend J; Schwaiger M; Combs SE; Habl G
    Radiat Oncol; 2018 Mar; 13(1):36. PubMed ID: 29490670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.
    Harris VA; Staffurth J; Naismith O; Esmail A; Gulliford S; Khoo V; Lewis R; Littler J; McNair H; Sadoyze A; Scrase C; Sohaib A; Syndikus I; Zarkar A; Hall E; Dearnaley D;
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):874-83. PubMed ID: 26104940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline.
    Vogel MME; Düsberg M; Stöhrer L; Dewes S; Sage EK; Borm KJ; Gschwend JE; Eiber M; Combs SE; Schiller K
    Eur Urol Oncol; 2022 Dec; 5(6):668-676. PubMed ID: 36280446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography/computed tomography in the staging and treatment of anal cancer.
    Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-institutional Development and Validation of Contouring Guidelines for Para-aortic Elective Nodal Irradiation in Prostate Cancer Based on Patterns of Involvement on Targeted Molecular Imaging Positron Emission Tomography/Computed Tomography.
    Saripalli AL; Lee B; Adams W; Bhandare N; Venkatesulu BP; Yoo RK; Price J; Harmon GA; Block AM; Friedman N; Harkenrider MM; Major EJ; Small W; Wagner RH; Welsh JS; Solanki AA
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):630-640. PubMed ID: 37201758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
    Mohammadkhani Shali S; Schmitt V; Behrendt FF; Winz OH; Heinzel A; Mottaghy FM; Eble MJ; Verburg FA
    Eur J Radiol; 2016 Aug; 85(8):1390-4. PubMed ID: 27423677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.